John Halamka, MD, president of Mayo Clinic Platform, and Melek Somai, MD, VP and chief technology and product officer at Inception Health, examine why AI-assisted development is reopening the build option for new application requests. They weigh build against buying in-suite or niche, the integration tax that sinks third-party tools, and how abstraction layers and multi-cloud strategy help health systems avoid vendor and LLM lock-in.
Source: Build Is Back: Panelists Say AI Tools Are Reopening the Make-vs-Buy Equation on healthsystemcio.com – Interviews & Webinars with Health System IT Leaders
FDA approves third over-the-counter opioid overdose nasal spray
The Food and Drug Administration (FDA) approved a third over-the-counter version of naloxone nasal spray Tuesday, in a move the agency said could save lives and reduce
